Pharmafile Logo
Pharmafocus logo
Advanced Search

JJ

Showing 15 posts of 221 posts found.

J&J backs out of $1.1 billion hep C deal, wiping 22.2% from Achillion’s stock

September 12, 2017
Manufacturing and Production, Sales and Marketing J&J, JJ, Johnson & Johnson, achillion, hepatitis C, pharma

Johnson & Johnson has announced that it is to back out of a $1.1 billion deal with Achillion Pharmaceuticals to …

News
virginia-7592

Has Trump’s power over pharma come to an end after Charlottesville?

August 31, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Donald Trump, J&J, JJ, Kenneth Frazier, MSD, President trump, Trump, life sciences, medicine, pharma, pharmaceuticals, president

In a shock move that was to have deeply resonant consequences, MSD Chairman and Chief Executive Officer Kenneth Frazier announced …

Feature

Johnson & Johnson face major lawsuit over vaginal mesh

July 4, 2017
Manufacturing and Production, Sales and Marketing J&J, JJ, Johnson & Johnson, lawsuit, vaginal mesh

Johnson & Johnson will face a lawsuit after 700 Australian women launched a class action suit over the failures of …

News
actelion

Actelion spin-off hit by blow shortly before buyout

June 9, 2017
Medical Communications, Research and Development Actelion, Idorsia, J&J, JJ

Idorsia, the spin-off R&D company of Actelion, has been hit a blow even before it has left the ground. The …

News
gavel

J&J launches lawsuit to block release of Remicade biosimilar

May 19, 2017
Medical Communications, Sales and Marketing J&J, JJ, Remicade, Samsung Bioepis

Samsung Bioepis gained approval to launch its biosimilar to Johnson & Johnson’s Remicade just last month, on 21 April, but …

News

FDA demands new warnings for J&J diabetes drug over amputation risk

May 17, 2017
Manufacturing and Production, Research and Development, Sales and Marketing J&J, JJ, Johnson & Johnson, diabetes

Johnson & Johnson has found itself in deep water again over the potentially harmful effects of its products. This time …

News
johnson_and_johnson_jj

J&J ordered to pay $5m over false marketing claims

April 6, 2017
Sales and Marketing J&J, JJ, lawsuit

Johnson & Johnson has become embroiled in yet another class-action lawsuit concerning its products; this time the company is accused …

News

Closure of Scottish J&J plant threatens 400 staff

March 10, 2017
Manufacturing and Production, Medical Communications J&J, JJ, Johnson & Johnson

Johnson & Johnson has announced its intention to shut down its surgical suture manufacturing facility in Livingston, Scotland which sees …

News

Lilly posts impressive psoriasis results in comparison study

March 6, 2017
Research and Development, Sales and Marketing J&J, JJ, Stelara, Taltz, lilly

Eli Lilly has revealed strong results in a study comparing its psoriasis treatment, Taltz (ixekizumab), to Johnson & Johnson’s Stelara. …

News
jj_2johnson_and_johnson

J&J latest pharma firm to volunteer pricing data

February 28, 2017
Manufacturing and Production, Medical Communications J&J, JJ, Johnson & Johnson

Johnson & Johnson released its pricing data, as promised, in February and it has simply revealed that its average price …

News
handshake-2056023_960_720

Integra bids $1.045 billion for J&J’s neurosurgery business

February 16, 2017
Sales and Marketing Codman, Integra, J&J, JJ, Johnson & Johnson

Integra, a medical technology company, have announced that it has made a binding offer to acquire Johnson & Johnson’s Codman …

News
johnson_and_johnson_jj

J&J breast implants “may have harmed thousands”, claims fresh lawsuit

February 6, 2017
Sales and Marketing J&J, JJ, Mentor Worldwide, breast implants

Mentor Worldwide, a unit of US pharma firm Johnson & Johnson, has been accused of selling defective breast implants and …

News
access_accelerated

22 pharma companies join forces for global non-communicable disease initiative

January 18, 2017
Research and Development BMS, Celgene, Eisai, Eli Lilly, GSK, J&J, JJ, MSD, Merck, Novartis, Pfizer, Roche, Sanofi, Takeda

The World Economic Forum Annual Meeting in Switzerland has seen the launch of Access Accelerated, a global initiative consisting of …

News
shutterstock_274590824

J&J hit by $1bn hip implant lawsuit

December 2, 2016
Medical Communications J&J, JJ, lawsuit

Johnson & Johnson have been hit with yet another payout to patients who claim its products caused them harm. First, …

News

J&J reportedly poised to acquire Europe’s biggest biotech

November 25, 2016
Sales and Marketing Actelion, J&J, JJ, Johnson and Johnson, acquisition

Johnson & Johnson could be eyeing a takeover of Swiss biotech Actelion, Europe’s biggest biotech, according to insiders, Bloomberg has …

News

Latest content

FDA approves Amgen’s Imdelltra for extensive-stage small cell lung cancer

May 17, 2024

AstraZeneca shares results from phase 3 trial of COVID-19 prevention drug

May 17, 2024

GSK pledges £45m to Fleming Initiative to fight AMR

May 16, 2024

NeuroSense partners with PhaseV on upcoming phase 3 ALS trial

May 16, 2024

AstraZeneca adds new heart failure target through collaboration with BenevolentAI

May 15, 2024